Study on Expression of lncRNA RGMB-AS1 and Repulsive Guidance Molecule B in Non-Small Cell Lung Cancer

Diagnostic Pathology - United Kingdom
doi 10.1186/s13000-015-0297-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Blockade of Repulsive Guidance Molecule B (RGMb) Inhibits Allergen-Induced Airways Disease

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Overexpression of lncRNA EGFR‑AS1 Is Associated With a Poor Prognosis and Promotes Chemotherapy Resistance in Non‑small Cell Lung Cancer

International Journal of Oncology
Cancer ResearchOncology
2018English

YY1-induced lncRNA ZFPM2-AS1 Facilitates Cell Proliferation and Invasion in Small Cell Lung Cancer via Upregulating of TRAF4

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

TOB1‑AS1 Suppresses Non‑small Cell Lung Cancer Cell Migration and Invasion Through a ceRNA Network

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

AFAP1‑AS1 Induces Cisplatin Resistance in Non‑small Cell Lung Cancer Through PI3K/AKT Pathway

Oncology Letters
Cancer ResearchOncology
2019English

Cytochrome P450 Expression (CYP) in Non-Small Cell Lung Cancer

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2007English

Significant Role of Psf3 Expression in Non-Small-Cell Lung Cancer

Cancer Science
Cancer ResearchMedicineOncology
2015English

Prognostic Significance of FoxM1 Expression in Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy